Validating the OCS-Plus against a clinical standard: A brief report

Area of Science:

• Neurology
• Cognitive Science
• Medical Technology

Background:

• Stroke frequently causes cognitive impairment, necessitating accurate screening tools.
• Current tools like the Montreal Cognitive Assessment (MoCA) are widely used but may have limitations in stroke populations.
• A dedicated, sensitive screening tool for post-stroke cognitive deficits is needed.

Purpose of the Study:

• To evaluate the sensitivity and clinical validity of the OCS-Plus, a tablet-based cognitive screening tool designed for stroke patients.
• To compare the performance of the OCS-Plus against the established MoCA screening tool in a post-stroke cohort.
• To determine the potential utility of the OCS-Plus as a sensitive measure for cognitive impairment after stroke.

Main Methods:

• Eighty-six patients admitted to Oxfordshire stroke wards were recruited over 22 months.
• All participants completed both the OCS-Plus and the MoCA cognitive screening tools.
• Convergent validity and sensitivity of the OCS-Plus were assessed in relation to the MoCA.

Main Results:

• The OCS-Plus exhibited good convergent validity when compared with the MoCA.
• The OCS-Plus demonstrated excellent sensitivity in identifying cognitive impairments in stroke patients.
• These findings suggest the OCS-Plus is a highly sensitive screening instrument for post-stroke cognitive assessment.

Conclusions:

• The OCS-Plus is a sensitive and clinically valid tool for cognitive screening in stroke survivors.
• Its high sensitivity suggests it is a valuable addition to the assessment of cognitive function post-stroke.
• The OCS-Plus offers a promising alternative or adjunct for clinicians seeking effective stroke-specific cognitive screening.